Over-the-counter sale of cough syrup barred

Following the Drugs Rules amendment, lozenges, pills, and tablets for cough will still be available over the counter; 24 children in M.P. died after consuming adulterated cough syrup last year

Medicinal syrups, including those used to treat coughs, can no longer be bought without a doctor’s prescription, according to a government notification issued on Tuesday (June 16, 2026) This means that over-the-counter sales of these syrups will no longer be allowed.

The Ministry of Health and Family Welfare notified the change to the Drugs Rules, 1945, which laid out the regulations pertaining to the Drugs and Cosmetics Act, 1940.

This comes after multiple fatalities caused by cough syrups adulterated with industrial solvents, including the deaths of at least 24 children in Madhya Pradesh last September. Cough syrups exported from India have also been linked to the deaths of more than 140 children in Africa and Central Asia since 2022.

Cough lozenges still available

Tuesday’s notification directed that the word ‘syrups’ be removed from the list of items that had been exempted from the provisions of the Act. The rules had earlier specified that ‘Syrups, lozenges, pills and tablets for cough’ would be exempted, meaning that cough lozenges, pills, and tablets will still be available over the counter.

The amendment follows a draft notification issued in December 2025 to which the government invited objections and suggestions from stakeholders and the public. The government said all comments received on the draft rules were considered before the final notification was issued.

Related Posts

Pune Police Bust Illegal Bodybuilding Drug Racket, 5 Arrested; 50 Mephentermine Injections Seized In Major Crackdown

Pune Police arrested five people for allegedly selling 50 vials of Mephentermine Sulphate Injection illegally for bodybuilding and intoxication. The accused reportedly had no valid drug licence or medical qualifications.…

Piramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion

Higher capacity utilisation, operating leverage and broad-based demand across CDMO, hospital generics and consumer healthcare are expected to support margins in FY27 Piramal Pharma expects to sustain mid-teen revenue growth…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Pune Police Bust Illegal Bodybuilding Drug Racket, 5 Arrested; 50 Mephentermine Injections Seized In Major Crackdown

Pune Police Bust Illegal Bodybuilding Drug Racket, 5 Arrested; 50 Mephentermine Injections Seized In Major Crackdown

Piramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion

Piramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion

13 Years after Oxytocin Order, HC Seeks Compilance Status

13 Years after Oxytocin Order, HC Seeks Compilance Status

Chemist shop sealed for selling abortion medication without prescription

Chemist shop sealed for selling abortion medication without prescription

Court Rejects Bail To Two In Multi-Crore Fake Drug Scam

Court Rejects Bail To Two In Multi-Crore Fake Drug Scam

Yashoda Medicity lifts Benchmark in Critical Care to New High

Yashoda Medicity lifts Benchmark in Critical Care to New High